SOD1 and lung cancer: The findings of this study suggest that serum SOD1 concentration could be included in the routine clinical characteristics of lung cancer patients as an additional diagnostic and prognostic biomarker; however, this still required corroboration by further, more detailed studies with larger cohorts.